O ver 30% of kidney transplant (KT) recipients experience early hospital readmission (EHR), or rehospitalization within 30 days of discharge after KT. 1 To appropriately manage these recipients, it is vital to understand the immediate and long-term ramifications of EHR. EHR increases the risk of subsequent hospitalization within the first year after KT. In addition, EHR is associated with inferior graft and patient survival. Deceased donor KT recipients who experience EHR are 1.43 times more likely to lose their graft and 1.50 times more likely to die compared to recipients who do not experience EHR. The same is true among live donor KT recipients who experience EHR; with a 1.54-fold increase in graft loss and a 1.45-fold increase in mortality. 2 Existing estimates of the association between graft loss, mortality, and EHR, may be misleading. These numbers suggest that upon readmission to the hospital, a recipient's risk for graft loss increases by approximately 50%, and their risk remains elevated indefinitely after the readmission is over. In other words, the risk of graft loss and death for recipients who are acutely ill and readmitted to the hospital is considered the same as the risk for recipients who experienced EHR in the past, survived that readmission, and are currently months or years postreadmission. Prior work in transplantation, and other fields, assumes that the risk associated with EHR is constant over time without considering the possibility that it may vary with time. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] The association between EHR and adverse transplant outcomes may be substantially different for KT recipients that are in the hospital experiencing EHR and those that have previously experienced EHR. Furthermore, it is unknown whether recipients who previously experienced EHR carry an increased risk of adverse outcomes for the remainder of their life or if that risk attenuates over time. Assuming a constant association may underestimate the risk attributable to the readmission hospitalization, and it may give an inaccurate estimate of the durability of that risk for recipients surviving postreadmission.
The objective of this study was to quantify the association between EHR and survival during 2 distinct periods: the EHR hospitalization and post-EHR. A second objective of the study was to determine whether the association between EHR and survival is constant during post-EHR follow-up.
MATERIALS AND METHODS

Study Population
The study population included 56 076 adult first-time KT recipients from December 1, 1999, through October 31, 2011, who had Medicare Part A and B as their primary insurance for at least 60 days before and 60 days after the date of transplant. Recipient, donor, and transplant characteristics were obtained from Organ Procurement Transplantation Network data. This study was reviewed by the institutional review board at Johns Hopkins School of Medicine and determined to qualify for an exemption under 45 Code of Federal Regulations 46.101(b) as study participants cannot be identified directly or through linked identifiers.
Exposure and Outcome Ascertainment
EHR hospitalization was captured using United States Renal Data System (USRDS) claims data. As specified in our previously published models of EHR after KT, EHR was defined as any hospitalization to an acute care facility within 30 days of discharge after initial KT hospitalization.
1,2 KT recipients who died before initial discharge after KT were excluded (n = 1743). KT recipients who had graft loss before discharge, but did not die, were also excluded from the analysis (n = 1489) because readmission in a recipient with a functioning graft at the time of discharge is mechanistically different than readmission of a recipient who has already lost their graft.
Association Between EHR and Survival
Cox proportional hazard models were used to estimate the hazard of death-censored graft loss and mortality associated with EHR. Separate models were used for deceased donor KT (DDKT) and live donor KT (LDKT). Each model was adjusted for recipient, donor, and transplant characteristics based on the Scientific Registry of Transplant Recipients risk adjustment models. 12 Models for DDKT were adjusted for age, sex, African American race, body mass index (BMI), preemptive transplant, cause of end stage renal disease (ESRD), peak panel reactive antibody, hepatitis C status, time on dialysis, HLA mismatch, pulsatile perfusion, cold ischemic time, donor/recipient weight ratio, donor race, terminal creatinine, donor hypertension, donor diabetes, extended criteria donor, donation after cardiac death, regional/national sharing.
Models for DDKT were also stratified based on occurrence of delayed graft function (DGF). Models for LDKT were adjusted for age, sex, African American race, BMI, preemptive transplant, cause of ESRD, peak panel reactive antibody, hepatitis C status, time on dialysis, HLA mismatch, recipient/ donor weight ratio, donor race. Recipients were censored at 5 years of follow-up, time of retransplant, or administratively at end-of-study. We used a clustered sandwich estimator for standard errors to account for possible centerlevel correlation. The proportional hazard assumption for each model was confirmed visually using log-log plots and Schoenfeld residuals.
We estimated the hazard of death-censored graft loss and mortality for two distinct periods: from EHR admission date to EHR discharge or death/graft loss (EHR hospitalization) and from EHR discharge date to death/graft loss or censorship (post-EHR). To avoid immortal person-time bias among KT recipients with EHR (requiring patient and graft survival up to the point of readmission) we used a standard method of late entries in which the recipients with EHR only contributed to the exposed risk set starting at the time of admission for the EHR hospitalization. Based on exploratory data analysis and prior hypotheses, the attributable hazard during the EHR hospitalization was treated as constant and we used a time-varying coefficient to estimate attributable hazard during the post-EHR period. In other words, the estimate for "EHR hospitalization" represents the hazard averaged over the entire hospitalization while the "post-EHR" hazard represents the hazard at the time of EHR discharge and that hazard can vary based on the amount of time since EHR discharge.
Reason for Readmission and Cause of Death
Reason for readmission was explored for recipients experiencing death/graft loss during the readmission hospitalization using Diagnosis-Related Group (DRG) codes. Cause of death, based on Organ Procurement and Transplantation Network data, was explored for 4 distinct recipient groups: recipients experiencing EHR and dying on the day of admission, recipients experiencing EHR and dying during the readmission hospitalization after at least 1 day of hospitalization, recipients that previously experienced readmission that died within 30 days after readmission discharge, and recipients that previously experienced EHR that died greater than 30 days after readmission discharge. Unfortunately, OPTN and USRDS data on cause of graft loss was missing for almost the entire study population; therefore we were unable to include this in our analysis.
Statistical Analysis
Confidence intervals are reported as per the method of Louis and Zeger, as previously described. 13, 14 All analyses were performed using STATA 14.0/MP for Linux (Stata Corp LP, College Station, TX).
RESULTS
EHR
Of 56 076 KT recipients, 17 739 experienced EHR (31.6%) ( Table 1 ). The median time from transplant discharge to EHR was 8 days (interquartile range [IQR], 4-15). Among recipients who experienced EHR, the length of stay for the EHR hospitalization ranged from 1 to 217 days with a median length of stay of 4 days (IQR, 2-7 days).
Crude Death-Censored Graft Loss and Mortality
Crude death-censored graft loss within 30 days of transplant discharge was 1.5% for recipients who experienced EHR and 0.2% for recipients without EHR (P < 0.001). Crude mortality within 30 days of transplant discharge was 0.8% for recipients who experienced EHR and 0.2% for recipients without EHR (P < 0.001). Crude death-censored graft loss within 1 year of transplant discharge was 7.2% for recipients who experienced EHR and 2.4% for recipients without EHR (P < 0.001). Crude mortality within 1 year of transplant discharge was 7.3% for recipients who experienced EHR and 2.5% for recipients without EHR (P < 0.001).
Association Between EHR and Survival During the EHR Hospitalization Period
During the EHR hospitalization, 1.2% (n = 218) of recipients lost their graft. Median time from EHR admission to death-censored graft loss was 4 days (IQR, 1-14), with 48 (22.0%) recipients losing their graft on the same day as EHR admission. Among recipients losing their graft during the EHR hospitalization, the 3 most common reasons for readmission included: kidney/urinary tract disorder (n = 111, 50.9%), unspecified surgical procedure (n = 11, 5.0%), and infection (n = 8, 3.7%). During the EHR hospitalization, 0.9% (n = 158) of recipients died. Median time from EHR admission to death was 12 days (IQR, 3-29), with 11 (7.0%) recipients dying on the same day as EHR admission. Among recipients dying during the EHR hospitalization, the 3 most common reasons for readmission included: kidney/ urinary tract disorder (n = 31, 19.6%), infection (n = 21, 13.3%), and respiratory disorder (n = 18, 11.4%).
In an adjusted model of DDKT recipients without DGF, during the EHR hospitalization, recipients who experienced EHR were 34.4 times more likely to lose their graft compared to recipients without EHR (adjusted hazard ratio [aHR], 24.6 34.4 47.9 , P < 0.001) ( Table 2 ). Among DDKT recipients with DGF, during the EHR hospitalization, recipients who experienced EHR were 15.2 times more likely to lose their graft compared to recipients without EHR (aHR, 10.8 15.2 21.4 , P < 0.001) ( Table 2) . LDKT recipients who experienced EHR were 36.7 times more likely to lose their graft compared to recipients without EHR (aHR, 18.1 36.7 74.2 , P < 0.001). In an adjusted model of DDKT recipients without DGF, during the EHR hospitalization, recipients who experienced EHR were 20.8 times more likely to die compared to recipients without EHR (aHR, 14.1 20.8 30.7 , P < 0.001). Among DDKT recipients with DGF, during the EHR hospitalization, recipients who experienced EHR were 12.8 times more likely to die compared to recipients without EHR (aHR, 9.03 12.8 18.0 , P < 0.001) ( Table 2) . LDKT recipients who experienced EHR were 18.2 times more likely to die compared to recipients without EHR (aHR, 9.00 18.2 41.3 , P < 0.001).
For recipients experiencing EHR and dying on the day of admission, the cause of death was missing for 9.1%. The 3 most common causes of death were cardiac events (45.5%), infection (27.2%), and cerebrovascular event or graft failure (9.1% each) ( Table 3 ). For recipients experiencing EHR and dying during the readmission hospitalization after at least 1 day of hospitalization, the cause of death was missing for 19.0%. The 3 most common causes of death were infection (34.7%), cardiac event (26.5%), and respiratory failure (7.5%) ( Table 3) .
Association Between EHR and Survival During the Post-EHR Period
During the post-EHR period, 33.6% (n = 5845) of recipients lost their graft, with a median time from EHR discharge to death-censored graft loss of 687 days (IQR, 238-1212) and 355 (6.1%) recipients losing their graft within 30 days of EHR discharge. During the post-EHR period, 22.5% (n = 3953) of recipients died, with a median time from EHR discharge to death of 766 days (IQR, 277-1265) and 158 (3.9%) recipients dying within 30 days of EHR discharge. In an adjusted model of DDKT recipients without DGF, during the post-EHR period, recipients who previously experienced EHR were 2.40 times more likely to lose their graft compared to recipients without EHR (aHR, 2.08 2.40 2.77 , P < 0.001) ( Table 2 ). Among DDKT recipients with DGF, during the post-EHR period, recipients who previously experienced EHR were 2.14 times more likely to lose their graft compared to recipients without EHR (aHR, 1.83 2.14 2.51 , P < 0.001) ( Table 2 ). LDKT recipients who previously experienced EHR were 2.50 times more likely to lose their graft compared to recipients without EHR (aHR, 2.00 2.50 3.13 , P < 0.001). In an adjusted model of DDKT recipients without DGF, during the post-EHR period, recipients who previously experienced EHR were 2.43 times more likely to die compared to recipients without EHR (aHR, 2.16 2.43 2.73 , P < 0.001) ( Table 2) . Among DDKT recipients with DGF, during the post-EHR period, recipients who previously experienced EHR were 2.16 times more likely to die compared to recipients without EHR (aHR, 1.83 2.16 2.54 , P < 0.001) ( Table 2) . LDKT recipients who previously experienced EHR were at a 2.34 times more likely to die compared with recipients without EHR (aHR, 1.90 2.34 2.88 , P < 0.001).
During the post-EHR period, the hazard of graft loss for recipients who previously experienced EHR decreased For recipients that previously experienced readmission that died within 30 days after readmission discharge, the cause of death was missing for 25.9%. The 3 most common causes of death were cardiac event (32.9%), infection (20.9%), and cerebrovascular event or respiratory failure (5.1% each) ( Table 3 ). For recipients that previously experienced EHR that died greater than 30 days after readmission discharge, the cause of death was missing for 51.2%. The 3 most common causes of death were cardiac event (15.7%), infection (13.5%), and malignancy (6.1%) ( Table 3) .
DISCUSSION
In this national study of 56 076 first-time KT recipients, we found that the association between EHR and adverse transplant outcomes is dynamic. The majority of death-censored Cause of death relevant to the EHR hospitalization for 4 recipient groups: recipients experiencing readmission and dying on the day of admission, recipients experiencing readmission and dying during the readmission hospitalization after at least 1 day of hospitalization, recipients that previously experienced readmission that died within 30 days after readmission discharge, and recipients that previously experienced readmission that died greater than 30 days after readmission discharge Hazard of death-censored graft loss and mortality during EHR hospitalization (readmission hospitalization) and after EHR discharge (postreadmission) All P values < 0.001. a Models adjusted for age, sex, African American race, BMI, preemptive transplant, cause of end stage renal disease, peak panel reactive antibody, hepatitis C status, time on dialysis, human leukocyte antigen mismatch, pulsatile perfusion, cold ischemic time, donor/recipient weight ratio, donor race, terminal creatinine, donor hypertension, donor diabetes, extended criteria donor, donation after cardiac death, regional/ national sharing. b Models adjusted for age sex, African American race, BMI, preemptive transplant, cause of end stage renal disease, peak panel reactive antibody, hepatitis C status, time on dialysis, human leukocyte antigen mismatch, recipient/donor weight ratio, donor race.
graft loss and mortality attributable to EHR occurred during the EHR hospitalization. During the EHR hospitalization, graft loss was 34.4 times higher among DDKT recipients without DGF, 15.2 times higher for DDKT recipients with DGF, and 36.7 times higher among LDKT recipients. Similarly, mortality was 20.8 times higher among DDKT recipients without DGF, 12.8 times higher among DDKT recipients with DGF, and 18.2 times higher among LDKT recipients. Immediately after readmission discharge, graft loss and mortality remained elevated, but much less so. Graft loss was 2.40 times higher among DDKT recipients without DGF, 2.14 times higher among DDKT recipients with DGF, and 2.50 times higher among LDKT recipients. Similarly, mortality was 2.43 times higher among DDKT recipients without DGF, 2.16 times higher among DDKT recipients with DGF, and 2.34 times higher among LDKT recipients. The hazard of death-censored graft loss and mortality continued to decrease with long-term post-EHR follow-up. During the readmission hospitalization and immediately post-EHR the majority of deaths were due to cardiac events and infection (72.7% among recipients experiencing EHR that died on the day of admission; 61.2% among recipients experiencing EHR that died later during the readmission hospitalization; 53.8% among recipients that previously experienced EHR and died within 30 days of readmission discharge). Current understanding of the association between EHR and mortality averages the risk attributable to EHR over the entire follow-up period. This approach may underestimate the risk during readmission hospitalization and may over-estimate the risk post-readmission. In our previous work on EHR after KT, we found that EHR was associated with 1.50 times higher mortality over 5 years of follow-up. 2 Our new approach demonstrates that the risk attributable to EHR is highest during the EHR hospitalization and declines over time. Outside the field of transplantation, readmission is a well-understood risk factor for mortality after surgery. After various surgical procedures, including pancreatectomy, coronary artery bypass grafting, orthopedic repairs, colectomy, esophagectomy, and lung cancer resection, EHR is associated with a 2.3-fold to 6.6-fold increase in the risk of mortality. [2] [3] [4] [8] [9] [10] [11] 15 Interestingly, studies with longer follow-up have a lower estimated risk ratio, indicating the effect may be a partial artifact of study design and follow-up time. Our study is not the first to use time-varying exposure methods to change the understanding of a biological process. [16] [17] [18] [19] Previous work by our group used similar methods to show that in pediatric KT recipients and liver transplant recipients the hazard of graft loss varies over time and is highest during late adolescence and early adulthood. 16, 17 Beyond the field of transplantation, several studies have used these methods. Bolard et al 18 used piecewise Cox proportional hazard models to show that the hazard of mortality by cancer stage varied with time post diagnosis. Similarly, Platt et al 19 used extended Cox proportional hazard models with time-varying covariates to better characterize predictors of fetal and infant mortality over the timeline of gestation. Our study is novel in treating EHR as a time-varying risk factor for adverse post-KT outcomes and to our knowledge is the first study to use these methods in the context of studying readmission.
Our findings may have practical implications for management of KT recipients experiencing EHR. In our previously published work on readmission after kidney transplantation we showed that 36% of readmissions were due to kidney/ urinary tract procedures and 12% were due to infection. 1 In the current study, we found that among the subgroup of recipients that lost their graft or died during the readmission hospitalization an issue with the kidney/urinary tract was the most common reason for readmission, however cardiac events and infection were the most common reasons for death. These findings suggest that although recipients may be readmitted due to issues with allograft function, death results from another pathologic process. Interventions to decrease the risk of infection and optimize cardiac function may mitigate the acute risk associated with EHR.
After EHR discharge, the risk of graft loss and mortality is attenuated but does not disappear completely and infection and cardiac events remain important causes of death among previously readmitted recipients in the first 30 days post-EHR. Clinicians need to remain mindful of the increased risk associated with readmission and common causes of death during the readmission hospitalization. Conversely, several years post-EHR, the remaining risk is minimal and recipients that make it to this point are unlikely to require specialized care.
Our study had several notable limitations. To ascertain readmission we had to limit our study population to recipients with Medicare as their primary insurer. Medicare primary KT-recipients may be systematically different than KT recipients with alternative insurance providers. However, Medicare is the leading primary insurer for approximately half of all KT recipients, making our study population an important sub-set of the general KT population. In addition, because all individuals with ESRD requiring dialysis are Medicare eligible, regardless of age or disability, our inferences should be minimally affected. A further limitation of our study is that we cannot determine whether recipients that lost their graft during readmission were readmitted because they were already losing their graft or they lost their graft as a result of readmission. In addition, we do not have granular detail about the cause of graft loss, which would help differentiate between recipients that are readmitted because they are doing poorly and recipients that are readmitted and then develop a poor outcome. Similarly, death during readmission could represent failure to rescue or death due to the readmission itself. Even though we cannot directly delineate the casual pathway between EHR and adverse outcomes, our study is the first to isolate the EHR hospitalization period as a source of substantial risk. An additional limitation is that many other factors have been shown to contribute to posttransplant outcomes, which were not explored in this study including health-related quality of life, socioeconomic status, and community-risk. [20] [21] [22] In conclusion, EHR remains a frequent and noteworthy occurrence post-KT. Recipients experiencing EHR should be managed with great care, as they are more susceptible to adverse outcomes both during the EHR hospitalization and for an extended period post-EHR.
